Exjade
Term · Oncology and biomedicine · MLC-T-ONC-003054
A drug used to treat too much iron in the blood caused by blood transfusions. It is being studied in the treatment of myelodysplastic syndromes (a group of diseases in which the bone marrow does not make enough healthy blood cells) and other conditions. Exjade binds to extra iron in the blood. The drug and the iron are passed from the body in urine. It is a type of chelating agent. Also called deferasirox.
| Identifier | MLC-T-ONC-003054 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | deferasirox |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003054",
"term": "Exjade",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat too much iron in the blood caused by blood transfusions. It is being studied in the treatment of myelodysplastic syndromes (a group of diseases in which the bone marrow does not make enough healthy blood cells) and other conditions. Exjade binds to extra iron in the blood. The drug and the iron are passed from the body in urine. It is a type of chelating agent. Also called deferasirox.",
"synonyms": [
"deferasirox"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/exjade/"
}
Record 7,029 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.